A Bayesian network meta-analysis: evaluating the efficacy and safety of targeted therapies in metastatic or advanced radioiodine-refractory differentiated thyroid cancer

BackgroundApproximately 5%–10% of patients with differentiated thyroid cancer (DTC) develop resistance to radioactive iodine (RAI), leading to unsatisfactory survival rates. The optimal medication for advanced or metastatic RAI-resistant differentiated thyroid cancer (RAIR-DTC) remains unclear.Metho...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Pin Wang, Ling Li, Ying Liu, Yushuya Shi, Xiangyu Zhang, Jian Wu
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2026-02-01
Schriftenreihe:	Frontiers in Oncology
Schlagworte:	Bayesian network time-trend analysis metastatic or advanced radioiodine-refractory differentiated thyroid cancer objective response rate progression-free survival target therapy
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1720670/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!